NEW YORK, NY / ACCESS Newswire / April 4, 2025 / Levi Korsinsky notifies investors that it has commenced an investigation of Aldeyra Therapeutics, Inc. ("Aldeyra Therapeutics, Inc.") (NASDAQ:ADLX) concerning possible violations of federal securities laws.On April 3, 2025, The company disclosed that the FDA issued a second Complete…Read More

You might also be interested in reading High Roller stock more than doubles on prediction markets partnership with Crypto.com.